Eintrag weiter verarbeiten
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Gespeichert in:
| Veröffentlicht in: | Blood 130(2017), 5, Seite 597-605 |
|---|---|
| Personen und Körperschaften: | , |
| Titel: | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis/ Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
| Format: | E-Book-Kapitel |
| Sprache: | Englisch |
| veröffentlicht: |
May 26, 2017
|
| Gesamtaufnahme: |
: Blood, 130(2017), 5, Seite 597-605
, volume:130 |
| Quelle: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
| LEADER | 02339caa a2200541 4500 | ||
|---|---|---|---|
| 001 | 0-1580087809 | ||
| 003 | DE-627 | ||
| 005 | 20220814221244.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180815s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2017-03-771220 |2 doi | |
| 035 | |a (DE-627)1580087809 | ||
| 035 | |a (DE-576)510087809 | ||
| 035 | |a (DE-599)BSZ510087809 | ||
| 035 | |a (OCoLC)1341017088 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sanchorawala, Vaishali |e VerfasserIn |0 (DE-588)1164558838 |0 (DE-627)1028976593 |0 (DE-576)510087876 |4 aut | |
| 245 | 1 | 2 | |a A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |c Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
| 264 | 1 | |c May 26, 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Prepublished online as Blood First Edition paper, 26 May 2017 | ||
| 500 | |a Gesehen am 15.08.2018 | ||
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 130(2017), 5, Seite 597-605 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnns |
| 773 | 1 | 8 | |g volume:130 |g year:2017 |g number:5 |g pages:597-605 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1182/blood-2017-03-771220 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 936 | u | w | |d 130 |j 2017 |e 5 |h 597-605 |g 9 |
| 951 | |a AR | ||
| 856 | 4 | 0 | |u https://doi.org/10.1182/blood-2017-03-771220 |9 LFER |
| 852 | |a LFER |z 2018-09-13T00:00:00Z | ||
| 970 | |c OD | ||
| 971 | |c EBOOK | ||
| 972 | |c EBOOK | ||
| 973 | |c Aufsatz | ||
| 935 | |a lfer | ||
| 900 | |a Schoenland, Stefan | ||
| 900 | |a Schönland, Stefan O. | ||
| 900 | |a Schönland, Stefan Olaf | ||
| 900 | |a Schonland, Stefan | ||
| 900 | |a Schönland, S. | ||
| 900 | |a Schönland, S. O. | ||
| 900 | |a Schonland, Stefan O. | ||
| 951 | |b XD-US | ||
| 980 | |a 1580087809 |b 0 |k 1580087809 |o 510087809 |c lfer | ||
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+phase+1%2F2+study+of+the+oral+proteasome+inhibitor+ixazomib+in+relapsed+or+refractory+AL+amyloidosis&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Sanchorawala%2C+Vaishali&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1528-0020 |
|---|
| _version_ | 1757949861314953216 |
|---|---|
| access_facet | Electronic Resources |
| author | Sanchorawala, Vaishali, Schönland, Stefan |
| author_facet | Sanchorawala, Vaishali, Schönland, Stefan |
| author_role | aut, aut |
| author_sort | Sanchorawala, Vaishali |
| author_variant | v s vs, s s ss |
| callnumber-sort | |
| collection | lfer |
| container_reference | 130(2017), 5, Seite 597-605 |
| container_title | Blood |
| ctrlnum | (DE-627)1580087809, (DE-576)510087809, (DE-599)BSZ510087809, (OCoLC)1341017088 |
| doi_str_mv | 10.1182/blood-2017-03-771220 |
| facet_avail | Online, Free |
| finc_class_facet | not assigned |
| finc_id_str | 0021239219 |
| footnote | Prepublished online as Blood First Edition paper, 26 May 2017, Gesehen am 15.08.2018 |
| format | ElectronicBookComponentPart |
| format_access_txtF_mv | Article, E-Article |
| format_de105 | Ebook |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_del152 | Buch |
| format_detail_txtF_mv | text-online-monograph-child |
| format_dezi4 | e-Book |
| format_finc | Article, E-Article |
| format_legacy | ElectronicBookPart |
| format_strict_txtF_mv | E-Article |
| geogr_code | not assigned |
| geogr_code_person | USA |
| hierarchy_parent_id | 0-266886647 |
| hierarchy_parent_title | Blood |
| hierarchy_sequence | 130(2017), 5, Seite 597-605 |
| hierarchy_top_id | 0-266886647 |
| hierarchy_top_title | Blood |
| id | 0-1580087809 |
| illustrated | Not Illustrated |
| imprint | May 26, 2017 |
| imprint_str_mv | May 26, 2017 |
| institution | DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2 |
| is_hierarchy_id | 0-1580087809 |
| is_hierarchy_title | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |
| isil_str_mv | LFER |
| issn | 1528-0020 |
| kxp_id_str | 1580087809 |
| language | English |
| last_indexed | 2023-02-16T01:40:30.797Z |
| marc024a_ct_mv | 10.1182/blood-2017-03-771220 |
| match_str | sanchorawala2017aphase12studyoftheoralproteasomeinhibitorixazomibinrelapsedorrefractoryalamyloidosis |
| mega_collection | Verbunddaten SWB, Lizenzfreie Online-Ressourcen |
| misc_de105 | EBOOK |
| multipart_link | 075961938 |
| multipart_part | (075961938)130(2017), 5, Seite 597-605 |
| names_id_str_mv | (DE-588)1164558838, (DE-627)1028976593, (DE-576)510087876, (DE-588)122405226, (DE-627)705896137, (DE-576)293255792 |
| oclc_num | 1341017088 |
| physical | 9 |
| publishDate | May 26, 2017 |
| publishDateSort | 2017 |
| publishPlace | |
| publisher | |
| record_format | marcfinc |
| record_id | 510087809 |
| recordtype | marcfinc |
| rvk_facet | No subject assigned |
| source_id | 0 |
| spelling | Sanchorawala, Vaishali VerfasserIn (DE-588)1164558838 (DE-627)1028976593 (DE-576)510087876 aut, A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini, May 26, 2017, 9, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Prepublished online as Blood First Edition paper, 26 May 2017, Gesehen am 15.08.2018, Schönland, Stefan 1969- VerfasserIn (DE-588)122405226 (DE-627)705896137 (DE-576)293255792 aut, Enthalten in Blood Washington, DC : American Society of Hematology, 1946 130(2017), 5, Seite 597-605 Online-Ressource (DE-627)266886647 (DE-600)1468538-3 (DE-576)075961938 1528-0020 nnns, volume:130 year:2017 number:5 pages:597-605 extent:9, https://doi.org/10.1182/blood-2017-03-771220 Verlag Resolving-System kostenfrei Volltext, https://doi.org/10.1182/blood-2017-03-771220 LFER, LFER 2018-09-13T00:00:00Z |
| spellingShingle | Sanchorawala, Vaishali, Schönland, Stefan, A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |
| swb_id_str | 510087809 |
| title | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |
| title_auth | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |
| title_full | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
| title_fullStr | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
| title_full_unstemmed | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
| title_in_hierarchy | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis / Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini, |
| title_short | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis |
| title_sort | phase 1 2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory al amyloidosis |
| url | https://doi.org/10.1182/blood-2017-03-771220 |